Review Article
Strategies to Improve the Efficiency of Transplantation with Mesenchymal Stem Cells for the Treatment of Ischemic Stroke: A Review of Recent Progress
Table 3
Recent studies reporting TCM and extracts that can improve the efficiency of MSC transplantation in ischemic stroke models.
| Drug name | Extraction source | Possible mechanisms | Animal model | Source of MSC | Research time | References |
| Salvia miltiorrhiza | Salvia miltiorrhiza Bunge | Promoting the antiapoptotic ability and survival of MSCs | Rat cerebral infarction model | Bone marrow (rat) | 2018 | Kim et al. [80] | Angelica gigas extract | Angelica gigas | Enhancing neovascularization | Rat cerebral infarction model | Bone marrow (rat) | 2018 | Kim et al. [85] | Borneol | Artemisia and Dipterocarpaceae | Suppressing apoptosis and promoting neurogenesis | Mouse cerebral infarction model | Fetal mice | 2017 | Zhang et al. [83] | Astragaloside and baicalin | | Improving the antiapoptosis and anti-inflammatory ability of MSCs by MAPK/ERK pathway | Cell inflammatory model induced by lipopolysaccharide | Bone marrow (mice) | 2017 | Zhu et al. [81] | Buyang Huanwu decoction | TCM prescription | Augmenting angio-miRNA in MSC-secreted exosomes | Rat cerebral infarction model | Not mentioned | 2015 | Yang et al. [78] | Buyang Huanwu decoction | TCM prescription | Upregulating VEGF and Ki-67 | Rat cerebral infarction model | Bone marrow (rat) | 2010 | Zhang et al. [77] |
|
|